129 related articles for article (PubMed ID: 15152615)
21. Fragments of Bence-Jones proteins: products of degradation or of synthesis by plasmocytoma cells?
Wetter O
Klin Wochenschr; 1970 Apr; 48(8):482-4. PubMed ID: 5534829
[No Abstract] [Full Text] [Related]
22. Treatment of multiple myeloma.
Waldenström J
Br J Haematol; 1968 Sep; 15(3):217-20. PubMed ID: 5681477
[No Abstract] [Full Text] [Related]
23. [High molecular-weight Bence Jones protein deposits in the kidney of a patient with plasma cell dyscrasia].
Kitabayashi A; Komatsuda A; Miura AB; Yamaguchi A; Takatsu H; Fujita K
Rinsho Ketsueki; 2000 Apr; 41(4):341-6. PubMed ID: 10846466
[TBL] [Abstract][Full Text] [Related]
24. [Cutaneous plasmacytomas following treatment of IgA kappa multiple myeloma].
Ortín X; Llorente A; Martínez S; Ugarriza A
Med Clin (Barc); 2004 Oct; 123(15):597-8. PubMed ID: 15535948
[No Abstract] [Full Text] [Related]
25. [An autopsied case of multiple myeloma with dimer and tetramer of Bence Jones protein in the serum and urine (author's transl)].
Sato K; Imai Y; Takayasu M; Tamaki M; Tange T
Rinsho Ketsueki; 1975 Jun; 16(6):620-7. PubMed ID: 1172058
[No Abstract] [Full Text] [Related]
26. [A case of Bence-Jones protein myeloma associated with amyloidosis].
Kurisu A; Takemasa Y
Nihon Naika Gakkai Zasshi; 1968 Nov; 57(11):1403-7. PubMed ID: 5752976
[No Abstract] [Full Text] [Related]
27. Primary amyloidosis and myelomatosis associated with excessive fibrinolytic acitivty.
Millard LG; Rowell NR
Br J Dermatol; 1976 May; 94(5):569-71. PubMed ID: 1268067
[TBL] [Abstract][Full Text] [Related]
28. [ON THE PATHOGENESIS AND CLINICAL DIAGNOSIS OF PARAPROTEINEMIA].
ANDREEVA NE; RYZHKOVA NP
Ter Arkh; 1963 Apr; 35():64-74. PubMed ID: 14063601
[No Abstract] [Full Text] [Related]
29. IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism.
Pizzolato M; Bragantini G; Bresciani P; Pavlovsky S; Chuba J; Vidal R; Rostagno A; Ghiso J
Br J Haematol; 1998 Jul; 102(2):503-8. PubMed ID: 9695965
[TBL] [Abstract][Full Text] [Related]
30. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
Holt JM; Robb-Smith AH; Callender ST; Spriggs AI
Br J Haematol; 1972 May; 22(5):633. PubMed ID: 4503794
[No Abstract] [Full Text] [Related]
31. [IgM myeloma].
Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
[No Abstract] [Full Text] [Related]
32. Bence jones proteins: nature, metabolism, detection and significance.
Deegan MJ
Ann Clin Lab Sci; 1976; 6(1):38-46. PubMed ID: 1247282
[TBL] [Abstract][Full Text] [Related]
33. Management of multiple myeloma.
Malpas JS
Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
[No Abstract] [Full Text] [Related]
34. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
Fujii H; Kanoh T
Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1553-61. PubMed ID: 6801164
[No Abstract] [Full Text] [Related]
35. Growth rates and responses to treatment in human myelomatosis.
Hobbs JR
Br J Haematol; 1969 Jun; 16(6):607-17. PubMed ID: 4184691
[No Abstract] [Full Text] [Related]
36. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
Alexanian R; Migliore PJ
J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
[No Abstract] [Full Text] [Related]
37. Melphalan in multiple myeloma.
Hoogstraten B; Sheehe PR; Cuttner J; Cooper T; Kyle RA; Oberfield RA; Townsend SR; Harley JB; Hayes DM; Costa G; Holland JF
Blood; 1967 Jul; 30(1):74-83. PubMed ID: 6028709
[No Abstract] [Full Text] [Related]
38. [Study on the Bence-Jones protein--study on paraproteins detected in myeloma patients with tetrameric Bence-Jones proteins (type kappa) (author's transl)].
Togawa A; Imamura Y
Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):571-81. PubMed ID: 816132
[No Abstract] [Full Text] [Related]
39. [A case of IgG-Bence Jones protein kappa type multiple myeloma complicated by adult Fanconi syndrome and osteomalacia].
Imagawa S; Ninomiya H; Wang ZB; Nakazawa M; Nakamura H; Yoda Y; Ohno A
Rinsho Ketsueki; 1984 Jan; 25(1):69-74. PubMed ID: 6431148
[No Abstract] [Full Text] [Related]
40. Long-term follow-up and therapy in multiple myeloma.
Vélez-García E; Maldonado N
Cancer; 1971 Jan; 27(1):44-50. PubMed ID: 4099699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
